These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3021869)

  • 1. Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection.
    Ward RL; Bernstein DI; Young EC; Sherwood JR; Knowlton DR; Schiff GM
    J Infect Dis; 1986 Nov; 154(5):871-80. PubMed ID: 3021869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus.
    Ward RL; Bernstein DI; Shukla R; Young EC; Sherwood JR; McNeal MM; Walker MC; Schiff GM
    J Infect Dis; 1989 Jan; 159(1):79-88. PubMed ID: 2535868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of adults rechallenged with a human rotavirus.
    Ward RL; Bernstein DI; Shukla R; McNeal MM; Sherwood JR; Young EC; Schiff GM
    J Infect Dis; 1990 Mar; 161(3):440-5. PubMed ID: 2155972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus.
    Ward RL; Knowlton DR; Schiff GM; Hoshino Y; Greenberg HB
    J Virol; 1988 May; 62(5):1543-9. PubMed ID: 3357205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus fecal IgA antibody response in adults challenged with human rotavirus.
    Bernstein DI; Ziegler JM; Ward RL
    J Med Virol; 1986 Dec; 20(4):297-304. PubMed ID: 3025350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and intestinal antibody responses to NSP4 enterotoxin of Wa human rotavirus in a gnotobiotic pig model of human rotavirus disease.
    Iosef C; Chang KO; Azevedo MS; Saif LJ
    J Med Virol; 2002 Sep; 68(1):119-28. PubMed ID: 12210439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary antibody titers in adults challenged with a human rotavirus.
    Ward RL; Pax KA; Sherwood JR; Young EC; Schiff GM; Bernstein DI
    J Med Virol; 1992 Mar; 36(3):222-5. PubMed ID: 1314287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental infection of pigtailed macaques with a simian rotavirus, YK-1.
    Westerman LE; Xu J; Jiang B; McClure HM; Glass RI
    J Med Virol; 2005 Apr; 75(4):616-25. PubMed ID: 15714478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance.
    Kapikian AZ; Wyatt RG; Levine MM; Yolken RH; VanKirk DH; Dolin R; Greenberg HB; Chanock RM
    J Infect Dis; 1983 Jan; 147(1):95-106. PubMed ID: 6296243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs.
    Ward LA; Rosen BI; Yuan L; Saif LJ
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1431-41. PubMed ID: 8757984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the duration of a primary immune response and the ID50 of ALA rabbit rotavirus in rabbits.
    Conner ME; Graham DY; Estes MK
    Arch Virol; 1997; 142(11):2281-94. PubMed ID: 9672593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an adult mouse model for studies on protection against rotavirus.
    Ward RL; McNeal MM; Sheridan JF
    J Virol; 1990 Oct; 64(10):5070-5. PubMed ID: 2168987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term production of rotavirus antibody and protection against reinfection following a single infection of neonatal mice with murine rotavirus.
    McNeal MM; Ward RL
    Virology; 1995 Aug; 211(2):474-80. PubMed ID: 7645251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avirulent rotavirus infections protect calves from disease with and without inducing high levels of neutralizing antibody.
    Bridger JC; Oldham G
    J Gen Virol; 1987 Sep; 68 ( Pt 9)():2311-7. PubMed ID: 2821172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses of homologous rotavirus infection in the mouse model.
    Burns JW; Krishnaney AA; Vo PT; Rouse RV; Anderson LJ; Greenberg HB
    Virology; 1995 Feb; 207(1):143-53. PubMed ID: 7871723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal model of rotavirus infection in rabbits--protection obtained without shedding of viral antigen.
    Hambraeus BA; Hambraeus LE; Wadell G
    Arch Virol; 1989; 107(3-4):237-51. PubMed ID: 2479363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of neutralizing antibodies against a candidate rotavirus vaccine in adults.
    Zissis G; Marissens D; Lambert JP; Marbehant P
    Dev Biol Stand; 1983; 53():201-8. PubMed ID: 6307775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
    Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
    J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group A rotavirus infection and age-dependent diarrheal disease in rats: a new animal model to study the pathophysiology of rotavirus infection.
    Ciarlet M; Conner ME; Finegold MJ; Estes MK
    J Virol; 2002 Jan; 76(1):41-57. PubMed ID: 11739670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group- and type-specific serologic response in infants and children with primary rotavirus infections and gastroenteritis caused by a strain of known serotype.
    Gerna G; Sarasini A; Torsellini M; Torre D; Parea M; Battaglia M
    J Infect Dis; 1990 Jun; 161(6):1105-11. PubMed ID: 2161039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.